Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Top Cited Papers
- 1 October 2021
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 398 (10309), 1407-1416
- https://doi.org/10.1016/s0140-6736(21)02183-8
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Inc Boulder
This publication has 29 references indexed in Scilit:
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort studyThe Lancet, 2021
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort studyThe Lancet, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingThe New England Journal of Medicine, 2021
- Neutralizing Activity of BNT162b2-Elicited SerumThe New England Journal of Medicine, 2021
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021Morbidity and Mortality Weekly Report (MMWR), 2021
- Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021Morbidity and Mortality Weekly Report (MMWR), 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Sociodemographic Characteristics of Members of a Large, Integrated Health Care System: Comparison with US Census Bureau DataThe Permanente Journal, 2012
- The Development of a Standardized Neighborhood Deprivation IndexJournal of Urban Health, 2006
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990